Inogen (INGN) Revenue Growth (3y) (2016 - 2026)
Inogen (INGN) Revenue Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | 0.73% |
| 10 | Inogen | 174.86 Mn | 64.69 Mn | 37.86 Mn | 5.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.65% |
| Dec 31, 2025 | -2.47% |
| Sep 30, 2025 | -4.29% |
| Jun 30, 2025 | -3.72% |
| Mar 31, 2025 | 0.78% |
| Dec 31, 2024 | -9.94% |
| Sep 30, 2024 | 3.14% |
| Jun 30, 2024 | -4.39% |
| Mar 31, 2024 | -3.54% |
| Dec 31, 2023 | 0.86% |
| Sep 30, 2023 | 7.92% |
| Jun 30, 2023 | 8.43% |
| Mar 31, 2023 | -6.57% |
| Dec 31, 2022 | 3.73% |
| Sep 30, 2022 | 4.72% |
| Jun 30, 2022 | 0.76% |
| Mar 31, 2022 | -3.77% |
| Dec 31, 2021 | 8.21% |
| Sep 30, 2021 | -5.28% |
| Jun 30, 2021 | 1.46% |